Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts Details-
Title Grant Type Focus Area Country Application Due Date Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2Release Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized AdultsRelease Date:Research Vaccines Italy Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult PopulationsRelease Date:Quality Improvement Vaccines Italy 2026 VAC US SMFM Maternal RSV QIRelease Date:Partner: Society for Maternal Fetal MedicineQuality Improvement Vaccines USA Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer Care: Visiting ProfessorshipRelease Date:Partner: Prostate Cancer FoundationEducation Oncology USA New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)Release Date:Education Oncology All Closing Knowledge Gaps and Building Practical Skills in HRRm Testing for Metastatic Prostate CancerRelease Date:Education Oncology All Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom Guideline Concordant Care and New Data for Patients with MIBC through la/mUCEducation Oncology USA Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast CancerRelease Date:Research Oncology Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Mexico, Spain, Taiwan, USA, United Kingdom Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophiliaRelease Date:Quality Improvement Inflammation & Immunology Australia, Chile, India, Italy, Spain, United Kingdom Advancing Real-World Evidence in Idiopathic Inflammatory Myopathies Through a German Disease RegistryRelease Date:Research Inflammation & Immunology Germany Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia InfectionsRelease Date:Research Inflammation & Immunology China Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China -
Title Grant Type Focus Area Country Application Due Date Pneumococcal Disease PreventionRelease Date:Chronic PainRelease Date:Bacterial InfectionsRelease Date:Pharmacy Pneumococcal Disease PreventionRelease Date:Smoking CessationRelease Date:Non-Small Cell Lung CancerRelease Date:Cardiovascular Risk in Rheumatoid ArthritisRelease Date:Opioid PainRelease Date:Adult Pneumococcal Disease PreventionRelease Date:Prevention of Stroke in WomenRelease Date:Oncology Educational Needs AssessmentsRelease Date:Extension GrantRelease Date:Appropriate use of Hormone Therapy in Postmenopausal WomenRelease Date:Antimicrobial StewardshipRelease Date:Appropriate Immunizations in Rheumatoid Arthritis PatientsRelease Date:Adolescent ImmunizationRelease Date:Chronic Pain CareRelease Date:Advanced Renal Cell CarcinomaRelease Date:HCP Perceptions on ImmunizationRelease Date:Adherence to Medications for Rheumatoid ArthritisRelease Date:Smoking Cessation ConferenceRelease Date:Extension Grant - Window 2Release Date:Oral Anticoagulants (Pfizer and BMS)Release Date:Barriers to Adult ImmunizationsRelease Date:Use of PROS in RARelease Date:Release Date:Attention-Deficit/Hyperactivity DisorderRelease Date:Symptomatic Vulvovaginal Atrophy in the Postmenopausal WomanRelease Date:Chronic Pain Care OutcomesRelease Date:Chronic Pain Care in the Patient-Centered Medical HomeRelease Date:Medication-Overuse Headache (MOH)Release Date:Reducing Cardiovascular Risk Globally Through Improved Dyslipidemia Awareness and TreatmentRelease Date:Community Oncologist Education and Support Systems ‐ Renal Cell Carcinoma and Hematologic MalignanciesRelease Date:Disparities in Adult ImmunizationsRelease Date:Global Bridges Smoking CessationRelease Date:Advances in Anticoagulation (Pfizer and BMS)Release Date:Cardiovascular Risk In Rheumatoid ArthritisRelease Date:Management of Flares in Rheumatoid Arthritis PatientsRelease Date:Immunizations in Young AdolescentsRelease Date:Pediatric and Adolescent MigraineRelease Date:Enabling Effective Conversations About Menopausal Vasomotor SymptomsRelease Date:Adult Immunization in Low- and Middle-Income CountriesRelease Date:Improving Chronic Pain OutcomesRelease Date:Chronic Pain Care- Interprofessional TeamRelease Date:Smoking CessationRelease Date:Patient Care in Rheumatoid ArthritisRelease Date:Disparities in Adult Pneumococcal VaccinationRelease Date:Chronic Pain Empowerment PlatformRelease Date: